{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":26,"n_cols":5,"rows_kept":26,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[18,2,18,3],[19,2,19,3],[23,2,23,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996208659403316"]
[null,null,"Titolo",null,"Biomarkers in heart disease / / edited by James A. de Lemos"]
[null,null,"Pubbl/distr/stampa",null,"Malden, Massachusetts : , : Blackwell Publishing, , 2008"]
[{"$nulls":4},"©2008"]
[null,null,"ISBN",null,"1-283-51409-5"]
[{"$nulls":4},"9786613826541"]
[{"$nulls":4},"1-4443-0020-2"]
[{"$nulls":4},"1-4443-0021-0"]
[null,null,"Descrizione fisica",null,"1 online resource (252 p.)"]
[null,null,"Collana",null,"AHA Clinical Series"]
[null,null,"Disciplina",null,"616.1/2075"]
[{"$nulls":4},"616.12075"]
[null,null,"Soggetti",null,"Diseases - Risk factors"]
[{"$nulls":4},"Biochemical markers"]
[{"$nulls":4},"Heart - Diseases - Diagnosis"]
[{"$nulls":4},"Heart - Diseases"]
[{"$nulls":4},"Heart - Diseases - Molecular diagnosis"]
[{"$nulls":4},"Biochemical markers - Diagnostic use"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"American Heart Association.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Contents; Contributors; Preface; Foreword; PART I Biomarkers for the Evaluation of Patients with Ischemic Heart Disease; 1 Protocols for diagnosing myocardial infarction; 2 Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes; 3 Challenges interpreting cardiac troponin values; 4 Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease; 5 Novel markers in patients with suspected acute coronary syndromes; PART I I Biomarkers for Evaluation of Patients with Heart Failure"]
[{"$nulls":4},"6 Use of natriuretic peptides in the diagnosis of heart failure7 Biomarkers for risk stratification in patients with heart failure; 8 Natriuretic peptides for disease monitoring in patients with chronic heart failure; PART I I I Biomarkers for Screening in Ambulatory Populations; 9 C-Reactive Protein; 10 Newer markers for population screening: focus on lipoprotein-related markers; PART I V A Look to the Future; 11 Moving toward personalized medicine; Index"]
[null,null,null,"Sommario/riassunto","Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.  The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scena"]